Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
103.20    0.00 (0.00%)
Bid:
82.00
Ask:
0.00
Spread: 22.20 (27.073%)
Market Cap: £169.19m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Appointment

20 Feb 2006 14:00

Yule Catto & Co PLC20 February 2006 Yule Catto & Co plc Appointment of Chief Executive Designate Yule Catto is an international producer of speciality chemicals, which aresupplied to global customers, ranging from manufacturers of medical gloves,paint and adhesives to the pharmaceuticals and cosmetics industries Alex Walker, Chief Executive for the past 20 years, will reach normal retirementage for Yule Catto senior executives in August 2006. The Board of Yule Catto &Co plc ("Yule Catto") is therefore pleased to announce that Adrian Whitfieldwill join the Board on 1st March 2006 as Chief Executive Designate. Mr Whitfield, aged 44, has a considerable industrial and internationalbackground, latterly as Chief Executive of the plastics division of D.S. Smithplc and prior to that as Vice President, European Operations, of CrownSimplimatic. His early industrial experience was gained with ICI Chemicals and Polymers,later applied and broadened as a consultant to manufacturing companiesthroughout Europe. He holds a BSc Hons. in mechanical engineering from ImperialCollege, London and is a member of The Institute of Mechanical Engineers. Anthony Richmond-Watson, Yule Catto Chairman, comments: "I am delighted to welcome Adrian to the Board. Together with the rest of theBoard, I am confident that his extensive experience will enable him to build onthe solid foundations laid by Alex Walker and our senior management team." 20 February 2006 YULE CATTO Tel: 01279 442791Anthony Richmond-Watson, ChairmanAlex Walker, Chief Executive COLLEGE HILL Tel: 020 7457 2020Gareth David The company has been notified by Mr Whitfield that there is no information whichis required to be disclosed pursuant to Listing Rule 9.6.13. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th Sep 20203:15 pmRNSDirector Declaration
6th Aug 20207:00 amRNSInterim Results for six months ended 30 June 2020
27th Jul 202010:00 amRNSPost Stabilisation Notice
16th Jul 20207:00 amRNSAppointment of Non-Executive Director
8th Jul 20204:16 pmRNSHolding(s) in Company
8th Jul 20204:14 pmRNSHolding(s) in Company
19th Jun 20207:00 amRNSSynthomer announces the pricing of senior notes
16th Jun 202011:54 amRNSPre Stabilisation Notice
16th Jun 202010:11 amRNSQ2 trading update
11th May 20205:21 pmRNSHolding(s) in Company
11th May 20209:03 amRNSDirector/PDMR Shareholding
11th May 20209:02 amRNSDirector/PDMR Shareholding
11th May 20208:59 amRNSDirector/PDMR Shareholding
11th May 20208:58 amRNSDirector/PDMR Shareholding
29th Apr 20203:17 pmRNSResult of AGM
29th Apr 20207:00 amRNSQ1 Trading and COVID-19 Update
1st Apr 20202:44 pmRNSCompletion of OMNOVA acquisition
1st Apr 20207:00 amRNSAnnual Financial Report
31st Mar 20207:00 amRNSDirector/PDMR Shareholding
31st Mar 20207:00 amRNSDirector/PDMR Shareholding
30th Mar 20207:00 amRNSAppointment of Deputy Chair and Chair-elect
30th Mar 20207:00 amRNSDirector/PDMR Shareholding
26th Mar 202010:17 amRNSEuropean Commission clearance for OMNOVA
23rd Mar 20207:00 amRNSDirector/PDMR Shareholding
16th Mar 20209:50 amRNSDirector/PDMR Shareholding
13th Mar 20205:29 pmRNSDirector/PDMR Shareholding
9th Mar 20202:45 pmRNSHolding(s) in Company
5th Mar 20207:00 amRNSPreliminary Results for the year ended 31 Dec 2019
31st Jan 20209:36 amRNSDirector Declaration
15th Jan 20202:21 pmRNSAcquisition of OMNOVA receives EC clearance
6th Dec 20197:00 amRNSAppointment of Broker
13th Nov 20192:53 pmRNSDirector/PDMR Shareholding
11th Nov 20197:00 amRNSDirector Declaration
25th Oct 20197:00 amRNSQ3 Trading Update
22nd Oct 20197:00 amRNSAGM Statement
11th Oct 20197:00 amRNSOmnova shareholders approval
14th Aug 20193:25 pmRNSHolding(s) in Company
13th Aug 201912:33 pmRNSDirector/PDMR Shareholding
6th Aug 20197:00 amRNSInterim Results for 6 months ended 30 June 2019
2nd Aug 201910:29 amRNSHolding(s) in Company
1st Aug 20199:05 amRNSHolding(s) in Company
31st Jul 201910:51 amRNSResults of Extraordinary General Meeting
30th Jul 20191:07 pmRNSDirector/PDMR Shareholding
30th Jul 20191:03 pmRNSDirector/PDMR Shareholding
30th Jul 20191:02 pmRNSDirector/PDMR Shareholding
30th Jul 20191:01 pmRNSDirector/PDMR Shareholding
30th Jul 201912:59 pmRNSDirector/PDMR Shareholding
30th Jul 201912:57 pmRNSDirector/PDMR Shareholding
30th Jul 201912:57 pmRNSDirector/PDMR Shareholding
30th Jul 201912:55 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.